The Office of Fair Trading (OFT) market study has today recommended a fundamental reform of the drug pricing system in the UK, which would see the current profit and price controls replaced with a value-based approach to pricing.
Researchers suggest a reason for racial disparity in breast cancer survival rates. African and African American women are much less likely to survive breast cancer surgery than their white counterparts and far more likely to get the disease before the menopause. Previous research suggests that those who undergo surgery for the disease before the menopause are more prone to relapse.
Boston College biologists have identified an alternative, diet-based method of treating brain cancer that does not involve administering toxic chemicals, radiation or invasive surgery.
Using gene chips to profile tumors before treatment, researchers at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary treatment for HER2-positive breast cancer.
Avastin, a relatively new type of drug that shrinks cancerous tumors by cutting off their blood supply, can slow the growth of the most common and deadly form of brain cancer, a pilot study conducted at Duke University Medical Center has found.
For the one in 18 men and women who will be diagnosed with cancer of the colon and rectum during their lifetime and over 150,000 people diagnosed on a yearly basis, today?s genetic research news offers some optimism.
Spearmint tea may help to get rid of unwanted hair growth in women, a medical condition known as hirsutism.
Thousands of children in hundreds of Australian towns and cities will soon be involved in a major national nutrition and physical activity survey, the Assistant Minister for Health and Ageing, Christopher Pyne, said today.
Lexington International LLC is proud to announce the landmark achievement of US Food & Drug Administration (FDA) clearance for their medical laser device, the HairMax LaserComb?.
Gene mutations governing a key brain enzyme make people susceptible to schizophrenia and may be targeted in future treatments for the psychiatric illness, according to MIT and Japanese researchers.